A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicidesVAN HERREWEGE, Yven; VANHAM, Guido; MICHIELS, Jo et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 10, pp 3684-3689, issn 0066-4804, 6 p.Article

The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimensARRIBAS, Jose R.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 3, pp 587-592, issn 0305-7453, 6 p.Article

Nonnucleoside Reverse Transcriptase Inhibitor Concentrations During Treatment Interruptions and the Emergence of Resistance: A Substudy of the ISS-PART TrialPIRILLO, Maria; PALMISANO, Lucia; VELLA, Stefano et al.AIDS research and human retroviruses. 2010, Vol 26, Num 5, pp 541-545, issn 0889-2229, 5 p.Article

Effect of Nucleoside and Nucleotide Analog Reverse Transcriptase Inhibitors on Cell-Mediated Immune FunctionsENOMOTO, Laura; ANDERSON, Peter L; SHAOBING LI et al.AIDS research and human retroviruses. 2011, Vol 27, Num 1, pp 47-55, issn 0889-2229, 9 p.Article

Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorFERRIS, Robert G; HAZEN, Richard J; SHORT, Steven A et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4046-4051, issn 0066-4804, 6 p.Article

Less than 95% adherence to nonnudeoside reverse-transcriptase inhibitor therapy can lead to viral suppressionBANGSBERG, David R.Clinical infectious diseases. 2006, Vol 43, Num 7, pp 939-944, issn 1058-4838, 6 p.Article

A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase InhibitorsNIKOLENKO, Galina N; DELVIKS-FRANKENBERRY, Krista A; PATHAK, Vinay K et al.Journal of virology. 2010, Vol 84, Num 10, pp 5238-5249, issn 0022-538X, 12 p.Article

Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase InhibitorLAI, Ming-Tain; MUNSHI, Vandna; TOUCH, Sinoeun et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2424-2431, issn 0066-4804, 8 p.Article

Reverse Transcriptase Inhibitors as Potential Colorectal MicrobicidesHERRERA, Carolina; CRANAGE, Martin; MCGOWAN, Ian et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 1797-1807, issn 0066-4804, 11 p.Article

How common is the non-nucleoside reverse transcriptase inhibitor mutation E138K in clinical practice?BRADSHAW, Daniel; MANDALIA, Sundhiya; NELSON, Mark et al.The Journal of infection. 2011, Vol 63, Num 2, pp 172-173, issn 0163-4453, 2 p.Article

Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance : evidence of transmitted resistance in rural South AfricaBARTH, Roos E; WENSING, Annemarie M; TEMPELMAN, Hugo A et al.AIDS (London). 2008, Vol 22, Num 16, pp 2210-2212, issn 0269-9370, 3 p.Article

Reverse transcriptase inhibitors alter uncoupling protein-1 and mitochondrial biogenesis in brown adipocytesRODRIGUEZ DE LA CONCEPCION, M. Luisa; YUBERO, Pilar; DOMINGO, Joan C et al.Antiviral therapy (London). 2005, Vol 10, Num 4, pp 515-526, issn 1359-6535, 12 p.Article

SAMHD1 Specifically Affects the Antiviral Potency of Thymidine Analog HIV Reverse Transcriptase InhibitorsBALLANA, Ester; BADIA, Roger; TERRADAS, Gerard et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4804-4813, issn 0066-4804, 10 p.Article

Topical Nonnucleoside Reverse Transcriptase Inhibitor MC 1220 Partially Prevents Vaginal RT-SHIV Infection of MacaquesSTOLTE-LEEB, Nicole; LODDO, Roberta; STAHL-HENNIG, Christiane et al.AIDS research and human retroviruses. 2011, Vol 27, Num 9, pp 933-943, issn 0889-2229, 11 p.Article

Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicityMAAGAARD, Anne; KVALE, Dag.Scandinavian journal of infectious diseases. 2009, Vol 41, Num 11-12, pp 808-817, issn 0036-5548, 10 p.Article

In combination, nucleoside reverse transcriptase inhibitors have significant effects on 3T3-L1 adipocyte lipid accumulation and survivalKOSMISKI, Lisa A; MILLER, Heidi L; KLEMM, Dwight J et al.Antiviral therapy (London). 2006, Vol 11, Num 2, pp 187-195, issn 1359-6535, 9 p.Article

Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic FailureLI, Jonathan Z; PAREDES, Roger; OSTERGAARD, Lars et al.The Journal of infectious diseases. 2013, Vol 207, Num 6, pp 893-897, issn 0022-1899, 5 p.Article

Profile of Leukocyte-Endothelial Cell Interactions Induced in Venules and Arterioles by Nucleoside Reverse-Transcriptase Inhibitors In VivoDE PABLO, Carmen; ORDEN, Samuel; PERIS, Jose E et al.The Journal of infectious diseases. 2013, Vol 208, Num 9, pp 1448-1453, issn 0022-1899, 6 p.Article

Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cellsDURAND-GASSELIN, Lucie; DA SILVA, David; BENECH, Henri et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 2105-2111, issn 0066-4804, 7 p.Article

Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitorsSTANKOV, Metodi V; LÜCKE, Thomas; DAS, Anibh M et al.Antiviral therapy (London). 2007, Vol 12, Num 2, pp 205-216, issn 1359-6535, 12 p.Article

Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondriaMORRIS, Gerald W; LACLAIR, Darcy D; MCKEE, Edward E et al.Antiviral therapy (London). 2010, Vol 15, Num 4, pp 495-505, issn 1359-6535, 11 p.Article

Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitorsAFONSO, Philippe V; MEKAOUCHE, Mourad; HERMINE, Olivier et al.Blood. 2010, Vol 116, Num 19, pp 3802-3808, issn 0006-4971, 7 p.Article

Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitorsHILL, Shawn A; LLOYD, Patricia A; MCDONALD, Shannon et al.The Journal of infectious diseases. 2003, Vol 188, Num 3, pp 424-427, issn 0022-1899, 4 p.Article

Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapyMOORE, Jeff D; ACOSTA, Edward P; JOHNSON, Victoria A et al.Antiviral therapy (London). 2007, Vol 12, Num 6, pp 981-986, issn 1359-6535, 6 p.Article

Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: A phase 1 studyGEWURZ, Benjamin E; JACOBS, Mark; PROPER, Jo Ann et al.The Journal of infectious diseases. 2004, Vol 190, Num 11, pp 1957-1961, issn 0022-1899, 5 p.Article